|
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
RECRUITINGN/ASponsored by North American Science Associates Ltd.
Actively Recruiting
PhaseN/A
SponsorNorth American Science Associates Ltd.
Started2025-10-01
Est. completion2026-06
Eligibility
Age40 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06872567
Summary
Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
Eligibility
Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria: * Patient has localized knee pain * Must be an appropriate candidate for arterial vascular access procedure Exclusion Criteria: * Known sensitivity or allergy to implant materials * Unable or unwilling to comply with study requirements
Conditions2
ArthritisKnee Osteoarthritis (Knee OA)
Interventions1
Locations1 site
University of Virginia
Find trials near these locations
Related trials
- Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture — Regionshospitalet Silkeborg
- Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain — LifeBridge Health
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNorth American Science Associates Ltd.
Started2025-10-01
Est. completion2026-06
Eligibility
Age40 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06872567